HiTech Health today announced that the company has been granted a Manufacturer’s/Importation Authorisation (MIA) for Investigational Medicinal Products (IMP) by the Medicines and Healthcare Products Regulatory Agency (MHRA). The company is now authorised to perform batch certification and import oversight for UK clinical trials. This achievement underscores commitment to meeting the highest standards of quality and safety in pharmaceutical products and advanced therapies, as set forth by the MHRA.

HiTech Health’s Qualified Personnel (QPs) can perform batch importation and certification for EU countries and the UK, thereby streamlining clinical supply chains for the sponsors. HiTech Health is dedicated to working closely with pharmaceutical and advanced therapy developers to bring new products to patients.

If you would like further information please email: info@hitech-health.com

Learn more about our services by clicking here

Find us on LinkedIn